Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)

EGX:MCRO Cash Flow Statement

Financials in millions EGP. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	131.22	115.73	-38.1	-272.65	173.84	147.93
Depreciation & Amortization	21.16	17.13	16.56	16.72	13.62	6.6
Other Amortization	0.58	0.38	0.38	0.51	0.68	-
Loss (Gain) From Sale of Assets	-	-	0.33	0.02	-	-
Asset Writedown & Restructuring Costs	-	-	-	24.42	-	-
Loss (Gain) From Sale of Investments	-5.04	-	-3.29	-	-	-
Provision & Write-off of Bad Debts	29.58	29.58	35.68	98.43	3.15	0.5
Other Operating Activities	49.86	31.37	37.03	47.87	20.5	20.47
Change in Accounts Receivable	-92.83	-1.33	-168.85	104.94	-33.58	-131.35
Change in Inventory	-72.04	-20.15	20.44	-67.65	-73.12	-19.33
Change in Accounts Payable	33.65	44.68	-18.57	20.25	27.74	16.69
Change in Other Net Operating Assets	-8.38	-56.4	43.94	-10.87	2.1	8.74
Operating Cash Flow	87.75	160.99	-74.45	-38.01	134.93	50.26
Operating Cash Flow Growth	567.27%	-	-	-	168.47%	9.39%

Investing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Capital Expenditures	-36.31	-42.48	-12.32	-6.44	-5.3	-5.81
Sale of Property, Plant & Equipment	0.61	0.62	-	0.04	-	-
Cash Acquisitions	-	-	-	-	-	-1.5
Sale (Purchase) of Intangibles	0.43	-	-	-	-3.5	-
Investment in Securities	-	-	3.29	-	-	-
Other Investing Activities	29.57	9.39	5.77	1.98	2.8	1.5
Investing Cash Flow	-5.7	-32.46	-3.26	-4.42	-6.01	-5.82

Financing Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Short-Term Debt Issued	-	97.37	226.81	293.77	286.33	7.25
Long-Term Debt Issued	-	102.58	154.63	-	-	-
Total Debt Issued	28.82	199.95	381.45	293.77	286.33	7.25
Short-Term Debt Repaid	-	-196.4	-317.81	-260.57	-212.08	-
Long-Term Debt Repaid	-	-18.37	-16.01	-12.25	-11.88	-4.58
Lease Payments	-21.27	-18.37	-16.01	-12.25	-11.88	-4.58
Total Debt Repaid	-312.44	-214.78	-333.83	-272.82	-223.96	-4.58
Net Debt Issued (Repaid)	-283.61	-14.82	47.62	20.95	62.37	2.67
Issuance of Common Stock	570.21	-	21.82	-	-	-
Repurchase of Common Stock	-	-	-	-29.97	-24.87	-
Common Dividends Paid	-0.3	-	-4.7	-60	-40	-46.82
Financing Cash Flow	286.11	-14.82	64.73	-69.02	-2.5	-44.15

Net Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Cash Flow	368.16	113.7	-12.97	-111.44	126.43	0.29

Free Cash Flow

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Free Cash Flow	51.44	118.51	-86.76	-44.44	129.63	44.44
Free Cash Flow Growth	-	-	-	-	191.66%	14.31%
Free Cash Flow Margin	4.86%	13.25%	-16.69%	-8.45%	17.77%	7.48%
Free Cash Flow Per Share	0.03	0.21	-0.15	-0.08	0.23	0.08
Levered Free Cash Flow	76.02	67.9	-99.42	84.42	75.76	-1
Unlevered Free Cash Flow	89.32	89.42	-61.51	102.85	84.18	4.1
Free Cash Flow After Leases	30.17	100.13	-102.78	-56.69	117.75	39.87

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash Interest Paid	21.13	27.37	32.22	25.27	10.14	6.26
Cash Income Tax Paid	0.1	0.1	0.05	48.79	45.71	42.95
Change in Working Capital	-139.6	-33.21	-123.04	46.67	-76.86	-125.25

Data Source: S&P Global Market Intelligence Last updated: Aug 8, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error